#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Hungary Italy Poland +1

  • Study of Azacitidine, Venetoclax, and Tagraxofusp for Patients with Higher-Risk Chronic Myelomonocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Spain

  • Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Germany Hungary Poland Romania +2

  • Study of AZD2962 tablets alone and with other medications in patients with myelodysplastic syndromes and dysplastic chronic myelomonocytic leukemia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Spain

  • Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of S227928 Alone and with Venetoclax for Patients with Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland France Germany

  • Study on Continued Treatment with Sabatolimab for Adults with High-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Unfit for Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Greece Italy Spain

  • Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Patients with Higher-Risk Chronic Myelomonocytic Leukemia (CMML)

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France

  • Study of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain